No Data
C.Q. Pharmaceutical Holding (SZSE:000950) Use Of Debt Could Be Considered Risky
C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Delivered A Weaker ROE Than Its Industry
c.q. pharmaceutical holding (000950.SZ) distributed 0.3 yuan per 10 shares in the first three quarters, with the registration date for equity on November 15th.
c.q. pharmaceutical holding (000950.SZ) announced that the company will implement equity distribution for the first three quarters of 2024, with a distribution of 1...
Private Companies Among C.Q. Pharmaceutical Holding Co., Ltd.'s (SZSE:000950) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 4.8% Last Week
Heavy Pharmaceuticals Holdings: Report for the third quarter of 2024
c.q. pharmaceutical holding (000950.SZ): net income in the third quarter was 54.137 million yuan, a year-on-year increase of 1269.44%.
C.q. Pharmaceutical Holding (000950.SZ) announced its third-quarter report on October 24th. In the third quarter of 2024, the company achieved a revenue of 19.913 billion yuan, an increase of 12.70% year-on-year; the net income attributable to shareholders of the listed company was 54.137 million yuan, an increase of 1,269.44% year-on-year; the net income after deducting non-recurring gains and losses was 58.7922 million yuan, an increase of 1,342.83% year-on-year; and the basic earnings per share was 0.03 yuan/share.
The Returns At C.Q. Pharmaceutical Holding (SZSE:000950) Aren't Growing
